352 related articles for article (PubMed ID: 9397218)
1. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
Ernst ME; Ernst EJ; Klepser ME
Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Croom KF; Goa KL
Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin and sparfloxacin: new quinolone antibiotics.
Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
[TBL] [Abstract][Full Text] [Related]
4. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
Goldstein EJ
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S25-30. PubMed ID: 8953103
[TBL] [Abstract][Full Text] [Related]
5. Levofloxacin, a second-generation fluoroquinolone.
North DS; Fish DN; Redington JJ
Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
[TBL] [Abstract][Full Text] [Related]
6. A critical review of the fluoroquinolones: focus on respiratory infections.
Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin: a therapeutic review.
Wimer SM; Schoonover L; Garrison MW
Clin Ther; 1998; 20(6):1049-70. PubMed ID: 9916602
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin.
Norrby SR
Expert Opin Pharmacother; 1999 Nov; 1(1):109-19. PubMed ID: 11249554
[TBL] [Abstract][Full Text] [Related]
9. Trovafloxacin: a new fluoroquinolone.
Alghasham AA; Nahata MC
Ann Pharmacother; 1999 Jan; 33(1):48-60. PubMed ID: 9972385
[TBL] [Abstract][Full Text] [Related]
10. Trovafloxacin: an overview.
Garey KW; Amsden GW
Pharmacotherapy; 1999 Jan; 19(1):21-34. PubMed ID: 9917076
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.
Davis R; Bryson HM
Drugs; 1994 Apr; 47(4):677-700. PubMed ID: 7516863
[TBL] [Abstract][Full Text] [Related]
12. Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.
Pechère JC; Gootz TD
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):405-12. PubMed ID: 9758283
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.
Girard AE; Girard D; Gootz TD; Faiella JA; Cimochowski CR
Antimicrob Agents Chemother; 1995 Oct; 39(10):2210-6. PubMed ID: 8619569
[TBL] [Abstract][Full Text] [Related]
14. Gatifloxacin: a review of its use in the management of bacterial infections.
Perry CM; Ormrod D; Hurst M; Onrust SV
Drugs; 2002; 62(1):169-207. PubMed ID: 11790160
[TBL] [Abstract][Full Text] [Related]
15. Levofloxacin: an updated review of its use in the treatment of bacterial infections.
Hurst M; Lamb HM; Scott LJ; Figgitt DP
Drugs; 2002; 62(14):2127-67. PubMed ID: 12269858
[TBL] [Abstract][Full Text] [Related]
16. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
[TBL] [Abstract][Full Text] [Related]
17. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
Martin SJ; Jung R; Garvin CG
Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
Langtry HD; Lamb HM
Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
[TBL] [Abstract][Full Text] [Related]
19. Trovafloxacin.
Haria M; Lamb HM
Drugs; 1997 Sep; 54(3):435-45; discussion 446. PubMed ID: 9279505
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing.
Perry AC; Prpa B; Rouse MS; Piper KE; Hanssen AD; Steckelberg JM; Patel R
Clin Orthop Relat Res; 2003 Sep; (414):95-100. PubMed ID: 12966282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
